| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.25 | 0.4 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.19 | 0.5 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.01 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.098 | 0.07 |